Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Other financing activities (2023 - 2024)

Pulse Biosciences (PLSE) has 2 years of Other financing activities data on record, last reported at $59000.0 in Q4 2024.

  • For Q4 2024, Other financing activities rose 1083.33% year-over-year to $59000.0; the TTM value through Dec 2025 reached $3000.0, up 250.0%, while the annual FY2024 figure was $281000.0, N/A changed from the prior year.
  • Other financing activities reached $59000.0 in Q4 2024 per PLSE's latest filing, up from -$56000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $59000.0 in Q4 2024 and bottomed at -$56000.0 in Q3 2024.